Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%

Author(s):  Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián

Issue:  Sep/Oct 2019 - Volume 23, Number 5
View All Articles in Issue

Page(s):  418-421

Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Page 1
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Page 2
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Page 3
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Page 4

Download in electronic PDF format for $65

Abstract:  There are multiple studies in the literature that support the use of povidone iodine in the preparation of the surgical field of cataract as the most effective means to reduce the bacteria present in the ocular surface and the risk of infection. The concentration of free iodine is related to the antiseptic activity of these compounds, being, therefore, a good indicator of its effectiveness. The objective of this study was to determine the amount of free iodine and the evolution of it in different formulations of povidone iodine eye drops. The povidone iodine 5% eye drops were prepared starting from Betadine 10% dermal or the active principle and using a solvent, phosphate-citrate buffer solution, and sodium chloride 0.9% or sterile water for injection. Aliquots of 5 mL were packed in low-absorption absorption eye drops, topaz glass vials, and polyethylene syringe. The determination of free iodine was made by volumetric titration. Titration was performed with 0.1 M sodium thiosulfate using a starch solution as an indicator. Of the 0.1 M sodium thiosulfate, 1 mL is equivalent to 12.69 mg of available iodine, and it is expressed as a percentage of free iodine in the iodized povidone (% free iodine). Eyewash titrations were performed by replacing the substance with 5 mL of eye drops and following the remaining steps. Valuations were made on days 0, 7, and 14, as well as the measurement of pH and osmolarity. The results show that there are no differences between the average results at the three measurements taken on days 0, 7, and 14. We conclude that the free iodine remains stable during the stability period of 14 days. Regarding the pH and osmolarity data, the authors believe that the best tolerated formula will be that elaborated with povidone iodine and a phosphate- citrate buffer solution.

Related Keywords: Silvia Berisa Prado, Pharm, Ana Cristina Riestra Ayora, Pharm, Adrián Trelles Campa, BSc, povidone-iodine eye drops, ophthalmologic surgery, complications, postoperative endophthalmitis, visual acuity, retinal detachment, eye injury, surgical field preparation, cataract surgery, ocular surface microbes, antiseptic agent, prophylaxis, solvents, free iodine, osmolarity, physical stability, chemical stability, storage containers, phosphate-citrate buffer solution

Related Categories: OPHTHALMICS, PEER-REVIEWED, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%
Berisa Prado Silvia
, Riestra Ayora Ana Cristina, Trelles Campa Adrián
Sep/Oct 2019
Pg. 418-421

Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
Sep/Oct 2015
Pg. 409

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jul/Aug 2022
Pg. 328

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jan/Feb 2023
Pg. 56

Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William
, Angelle Patricea (Patsy), Chang Richard I
Nov/Dec 2009
Pg. 506-515

Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Robert Marie-Claude
, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Sep/Oct 2014
Pg. 418-426

Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana
, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009
Pg. 540-543

Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis
, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
May/Jun 2015
Pg. 252-260

PVP Iodine 10% Antiseptic Cream
Allen Loyd V Jr
May/Jun 2017
Pg. 237

Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves
, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022
Pg. 336-341

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill
, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014
Pg. 370-377

Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 319

Ophthalmic Toning-Lubricating Drops
Allen Loyd V Jr
Jan/Feb 2010
Pg. 70

Canine Eye Ulceration Drops
Allen Loyd V Jr
Jul/Aug 1997
Pg. 253

Iodine 2% in Oil Injection
Allen Loyd V Jr
Mar/Apr 2001
Pg. 131

Iodine and Methylsalicylate Ultrasound Ointment
Allen Loyd V Jr
Sep/Oct 2002
Pg. 365

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
May/Jun 2017
Pg. 215-220

Stability of Venlafaxine Immediate-Release Suspensions
Donnelly Ronald F
, Wong Keith, Goddard Rob, Johanson Christel
Jan/Feb 2011
Pg. 81-84

Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Nov/Dec 2020
Pg. 482-490